Investing Is Beam Therapeutics (NASDAQ:BEAM) Too Late to the Game? – TipRanks Financial Blog2024-03-30 Beam Therapeutics (NASDAQ:BEAM) is a gene enhancing firm — one which will get much less consideration than its friends. Nonetheless,…
Investing Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results – TipRanks Financial Blog2024-03-25 Lead program in sufferers with lymphoma demonstrated preliminary security and efficacy outcomes with sustained full response in first examine participant…